12:00 AM
 | 
Jan 03, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Willfact regulatory update

LFB has received a positive review of Willfact under the EU Mutual Recognition Procedure to stop and prevent bleeding in patients with severe von Willebrand disease (vWD) in 15 countries. The plasma-derived human von Willebrand...

Read the full 165 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >